BackVitrolife AB (publ) Overview

Vitrolife AB (publ) Receivables

Track Vitrolife AB (publ)'s receivables ($910M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$909.00M
↑ 18.21% YoYΔ $140.00M vs prior year quarter

Peer trimmed avg / median

Loading

Vitrolife AB (publ) Receivables History

Loading

Vitrolife AB (publ) vs. peers: Receivables Comparison

Loading

Vitrolife AB (publ) Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Vitrolife AB (publ) (VITR.ST) FAQ

Vitrolife AB (publ) (VITR.ST) currently reports a receivables of $910M as of June 2026. That compares with $770M in the prior-year period — up 18.2% year over year. Use the charts on this page to explore Vitrolife AB (publ)'s receivables history and peer comparisons.

Vitrolife AB (publ)'s receivables increased from $770M to $910M — a 18.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Vitrolife AB (publ) reported $910M in receivables as of June 2026. That compares with $770M in the prior-year period — up 18.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $910M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vitrolife AB (publ), and consider following VITR.ST for alerts when major investors trade the stock.